New drug shows promise for epilepsy

German researchers say a new drug shows promise for treating epileptic seizures and may prove beneficial for bi-polar disorder and neuropathic pain. The study, which appears in the journal Epilepsia, shows that Eslicarbazepine (ESL) may be useful as a treatment for patients whose epilepsy symptoms aren't controlled by existing medications. A drug trial conducted in five European countries found that ESL fully eliminated seizures in 24 percent of test patients.... Whole article "www.sciencedaily.com":[ http://www.sciencedaily.com/upi/index.php?feed=Science&article=UPI-1-20070406-22542300-bc-us-epilepsy.xml]

---

Related articles

In vitro responsiveness of human-drug-resistant tissue to antiepileptic drugs: - Pharmacoresistance in epileptic patients may be ascribed to at least two, not mutually exclusive, mechanisms: a pharmacokinetic mechanism and a decreased sensitivity or availability of targets to antiepileptic drugs (AEDs; i (8.6.2006)